FGF5 and cancer: The majority of the DEGs, e.g., SOX11, TBX21, FAM3B, FGF5, HNF1A, MYB, and PLAC8 have been reported to function as promoters or biomarkers in various cancer types [44,45,46,47,48,49,50].